Warner Bros. Discovery, Inc.
PYRROLOPYRIMIDINE COMPOUND AND USE THEREOF
Last updated:
Abstract:
The present invention relates to a pyrrolopyrimidine compound used as a JAK inhibitor, and the use thereof in the preparation of a drug for treating a JAK1- and/or JAK2-associated disease, and in specifically relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
5 Jun 2020
Issue date:
21 Jul 2022